2Barbui T, Thiele J, Passamonti F, et al. Survival and disease progression in essential thrombocythemia are significantly in- fluencedby accurate morphologic diagnosis: an international study[-J. J Clin Oncol,2011,29(23) :3179-3184.
6Chen B, Zhao WL, Jin J, et al. Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries[J]. Leukemia, 2005, 19(5): 767-775.
7Matsuda A, Germing U, Jinnai L, et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes [J ]. Blood, 2005, 106(8): 2633-2640.
8Lee JH, Lee JH, Shin YR, et al. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome [J]. Leukemia, 2003, 17(2) : 305-313.
9Intragumtornchai T, Prayoonwiwat W, Swasdikul D, et al. Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases[J]. Leuk Res, 1998, 22(5) : 453-460.
10De Souza b-T, Omellas MH, Otero DC, et al. Chromosomal alterations associated with evolution from myelodysplastie syndrome to acutemyeloid leukemia[J]. Leuk Res, 2000, 24(10): 839-848.
